BillionToOne, Inc. BillionToOne, Inc.

BillionToOne, Inc.

BLLN

Classement en actions #3474
BillionToOne, Inc. is a specialized diagnostics company that innovates by... BillionToOne, Inc. is a specialized diagnostics company that innovates by precisely quantifying biological data to create advanced molecular diagnostic solutions. Central to their operations is a cutting-edge molecular counting platform, meticulously engineered to identify and measure individual DNA molecules, thereby significantly enhancing the precision of disease detection. Their product portfolio includes: UNITY Complete: A non-invasive prenatal screen that assesses a fetus's risk for aneuploidies, recessive genetic conditions, and fetal antigens, all from a simple maternal blood sample. Northstar Select: A liquid biopsy test designed to pinpoint specific mutations present in tumors, encompassing deletions, insertions, and point mutations. Northstar Response: A diagnostic tool that enables continuous tracking of cancer progression through detailed methylation assessment. Established in 2016, BillionToOne, Inc. conducts its operations from its headquarters located in Menlo Park, California.
Prix de l'action
$105.11
Capitalisation boursière
$4.96B
Changement (1 jour)
1.56%
Changement (1 an)
-
Pays
US
Échange BillionToOne, Inc. (BLLN)

Catégorie

Healthcare
Historique des divisions d’actions pour BillionToOne, Inc. (BLLN)
L’action BillionToOne, Inc. (symbole : BLLN) a subi un total de 0 divisions.
La division la plus récente a eu lieu le Oct 22, 2026.
Une action BLLN achetée avant le Oct 22, 2026 équivaudrait aujourd’hui à 0 actions BLLN.
Liste des divisions d’actions
Année Division Multiplicateur Multiplicateur cumulatif
Pas assez de données pour les dates fournies.
Divisions d’actions d’entreprises similaires ou concurrentes
Entreprise Nombre de divisions d’actions Multiplicateur cumulatif Pays
8 x34
US
7 x47
US
0 -
US
0 -
CN
1 x1
US